Literature DB >> 9511818

Characterisation and expression of fatty acid modifying enzyme produced by Staphylococcus epidermidis.

N R Chamberlain1, S A Brueggemann.   

Abstract

The production of fatty-acid modifying enzyme (FAME) - first identified as a possible virulence factor in Staphylococcus aureus - has also been identified in S. epidermidis. This extracellular enzyme inactivates bactericidal fatty acids by esterifying them to cholesterol. FAME may provide protection for S. epidermidis by inactivating these lipids present on the skin. Over 88% of 51 randomly collected S. epidermidis isolates produced FAME; 92.2% and 13.7% of the same strains produced lipase and slime, respectively. There appeared to be no correlation of lipase activity or slime production with FAME production. The temperature optimum for FAME was between 20 degrees C and 35 degrees C, and the pH optimum was 6.0. Optimal enzyme activity was present at NaCl concentrations of between 250 and 500 mM. FAME was not detected in culture filtrates until early stationary phase, indicating some regulatory control over enzyme production.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9511818     DOI: 10.1099/00222615-46-8-693

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  9 in total

1.  What Lives On Our Skin: Ecology, Genomics and Therapeutic Opportunities Of the Skin Microbiome.

Authors:  Tiffany C Scharschmidt; Michael A Fischbach
Journal:  Drug Discov Today Dis Mech       Date:  2013-12-01

2.  Antibacterial fatty acids destabilize hydrophobic and multicellular aggregates of biofilm in S. aureus.

Authors:  Zulfiqar Ali Mirani; Shagufta Naz; Fouzia Khan; Mubashir Aziz; Muhammad Naseem Khan; Seema Ismat Khan
Journal:  J Antibiot (Tokyo)       Date:  2016-06-29       Impact factor: 2.649

3.  Characterization of the major secreted zinc metalloprotease- dependent glycerophospholipid:cholesterol acyltransferase, PlaC, of Legionella pneumophila.

Authors:  Sangeeta Banerji; Mayte Bewersdorff; Björn Hermes; Nicholas P Cianciotto; Antje Flieger
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

Review 4.  Molecular basis of Staphylococcus epidermidis infections.

Authors:  Michael Otto
Journal:  Semin Immunopathol       Date:  2011-11-19       Impact factor: 9.623

Review 5.  Staphylococcus epidermidis--the 'accidental' pathogen.

Authors:  Michael Otto
Journal:  Nat Rev Microbiol       Date:  2009-08       Impact factor: 60.633

6.  Characterization of fatty acid modifying enzyme activity in staphylococcal mastitis isolates and other bacteria.

Authors:  Thea Lu; Joo Youn Park; Kelleen Parnell; Larry K Fox; Mark A McGuire
Journal:  BMC Res Notes       Date:  2012-06-22

7.  Characterisation of a cell wall-anchored protein of Staphylococcus saprophyticus associated with linoleic acid resistance.

Authors:  Nathan P King; Türkan Sakinç; Nouri L Ben Zakour; Makrina Totsika; Begoña Heras; Pavla Simerska; Mark Shepherd; Sören G Gatermann; Scott A Beatson; Mark A Schembri
Journal:  BMC Microbiol       Date:  2012-01-15       Impact factor: 3.605

Review 8.  The Candidate Antigens to Achieving an Effective Vaccine against Staphylococcus aureus.

Authors:  Hamid Reza Jahantigh; Sobhan Faezi; Mehri Habibi; Mehdi Mahdavi; Angela Stufano; Piero Lovreglio; Khadijeh Ahmadi
Journal:  Vaccines (Basel)       Date:  2022-01-27

9.  The Staphylococcus aureus response to unsaturated long chain free fatty acids: survival mechanisms and virulence implications.

Authors:  John G Kenny; Deborah Ward; Elisabet Josefsson; Ing-Marie Jonsson; Jason Hinds; Huw H Rees; Jodi A Lindsay; Andrej Tarkowski; Malcolm J Horsburgh
Journal:  PLoS One       Date:  2009-02-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.